ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible

May 26, 1995

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Robert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases

March 14, 2014

Roswell Park Wins Competition for Organ Systems Coordinating Center

May 18, 1984

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997